{"id":36271,"date":"2016-07-27T09:58:00","date_gmt":"2016-07-27T13:58:00","guid":{"rendered":"http:\/\/www.bumc.bu.edu\/busm\/?p=36271"},"modified":"2016-07-27T09:58:00","modified_gmt":"2016-07-27T13:58:00","slug":"ikezu-honored-by-alzhemiers-association-for-most-impactful-study-in-the-last-two-years","status":"publish","type":"post","link":"https:\/\/www.bumc.bu.edu\/camed\/2016\/07\/27\/ikezu-honored-by-alzhemiers-association-for-most-impactful-study-in-the-last-two-years\/","title":{"rendered":"Ikezu Honored by Alzhemier\u2019s Association for  \u201cMost Impactful Study in the Last Two Years\u201d"},"content":{"rendered":"<p><a href=\"http:\/\/profiles.bu.edu\/Tsuneya.Ikezu\">Tsuneya Ikezu<\/a><a href=\"http:\/\/profiles.bu.edu\/Tsuneya.Ikezu\"><img loading=\"lazy\" src=\"\/camed\/files\/2016\/07\/Tsuneya-Ikezu.jpg\" alt=\"Tsuneya Ikezu\" class=\"alignright wp-image-36272 size-full\" height=\"186\" width=\"301\" \/><\/a>, MD, PhD, professor of pharmacology &amp; experimental therapeutics and neurology at Boston University School of Medicine (BUSM), recently received the Alzheimer\u2019s Association\u2019s Inge Grundke-Iqbal Award for Alzheimer\u2019s Research. The award was presented at the Alzheimer&#8217;s Association International Conference<sup>\u00ae <\/sup>2016 in Toronto.<\/p>\n<p>Ikezu received the award for research that found brain immune cells called microglia may play an adverse role in transporting toxic tau protein during the early stages of Alzheimer\u2019s disease. In the study, Ikezu and colleagues found that removing microglia from the brains of mice suppressed the spread of tau from one brain region to another. They also found that small vesicles called exosomes are implicated in the spared of tau. Researchers suggest this may be a viable therapeutic pathway to slow the progression of Alzheimer\u2019s.<\/p>\n<p>The significant findings were detailed in a paper, \u201cDepletion of microglia and inhibition of exosome synthesis halt tau propagation,\u201d published in the journal <em>Nature Neuroscience<\/em> in November 2015. <span style=\"text-decoration: line-through;\"><\/span><\/p>\n<p>\u201cThe research in Dr. Ikezu\u2019s paper breaks new ground and suggests an important, new direction for future research,\u201d said Maria C. Carrillo, PhD, chief science officer at the Alzheimer\u2019s Association. \u201cEvery contribution that offers new insight into the role of tau in Alzheimer\u2019s disease is important to advancing our efforts to slow and eventually prevent it \u2013 especially now that the first drugs targeting tau in Alzheimer\u2019s are reaching late-stage clinical trials. We commend Dr. Ikezu and his fellow researchers for expanding knowledge in this important area.\u201d<\/p>\n<p>Ikezu\u2019s research focuses on the role of neuroinflammation in the pathophysiology of dementia and as a potential therapeutic target in Alzheimer\u2019s disease, Frontotemporal Dementia and chronic traumatic encephalopathy. Dr. Ikezu has been a member of BU\u2019s Alzheimer\u2019s Disease Center since 2011.<\/p>\n<p>The Inge Grundke-Iqbal Award for Alzheimer\u2019s Research is granted to the senior author of the most impactful study published in Alzheimer\u2019s research during the two calendar years preceding AAIC. The award was created to honor Inge Grundke-Iqbal, Ph.D., who served as Professor and Head of Neuroimmunology at the New York State Institute for Basic Research in Development Disabilities from 1977 until her passing in September 2012. A world renowned scientist and Alzheimer\u2019s disease researcher, Dr. Grundke-Iqbal made several seminal findings in the biology of Alzheimer\u2019s disease and related conditions, including a landmark discovery of tau in neurofibrillary tangles that opened a new area of research in neurodegeneration.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The professor of pharmacology &#038; experimental therapeutics and neurology recently received the Alzheimer\u2019s Association\u2019s Inge Grundke-Iqbal Award for Alzheimer\u2019s Research. <\/p>\n","protected":false},"author":10773,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[127,89,91,126,90],"tags":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts\/36271"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/users\/10773"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/comments?post=36271"}],"version-history":[{"count":2,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts\/36271\/revisions"}],"predecessor-version":[{"id":36274,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/posts\/36271\/revisions\/36274"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/media?parent=36271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/categories?post=36271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/camed\/wp-json\/wp\/v2\/tags?post=36271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}